Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Laureate Pharma | Contract Pharma
Breaking News, Promotions & Moves

Laureate Pharma

Steven R. Johnson has been appointed vice president of business development at Laureate Pharma.

Steven R. Johnson has been appointed vice president of business development at Laureate Pharma. Mr. Johnson will be responsible for the company’s worldwide business development activities, including sales, marketing, business development and project management, supporting the company’s contract development, protein manufacturing, testing and aseptic filling businesses.

“Steve brings a proven track record of sales management in the biologics market combined with extensive senior relationships,” said Michael A. Griffith, chief executive officer of Laureate. “He is an industry leader and brings to Laureate an impressive background that includes broad international business development experience in contract manufacturing of monoclonal antibodies, biopharmaceuticals and chemical APIs.”

Mr. Johnson joins the company from Lonza, where he served most recently as vice president global business development, and previously as vice president, sales and business development, North America. In both positions, he supported several of Lonza’s contract manufacturing business units, including cell culture protein manufacturing, microbial protein production and stem cell production. Previously, he held the position of vice president, sales North America for Degussa Fine Chemicals.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters